An underground market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Investigational Drug Gaining Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.
Active Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where groups with thousands of members share comparison images, injection guides and claims of rapid UK delivery. Sellers promote the substance there before directing customers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Professionals Express Worries
However, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in users administering products of unknown origin.
Several professionals stated the demand for retatrutide could be connected to the rising cost of approved weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.
Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and customer regulations, risking fines, prosecution or prison.
Platform Response and Material Removal
According to TikTok, the service has removed violative content and prohibited associated keywords and query recommendations. The organization stated it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.
Online Trading Activities
Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, filled with photos of slimming results, positive reviews and detailed guides for preparing or injecting at home.
After moments of joining one group, a vendor shared contact information, where the majority of purchases take place. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about body mass, medical conditions or previous experience.
Item Information and Costs
Within these communities, messages display dark colored packages with postal service stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When asked how long a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for the messaging service stated it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting materials they can’t verify. Even if the research behind this drug is valid, these online products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.
Her staff has already encountered patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental product not yet approved … may subject users to potentially significant health risks”.
